is the fda banning tirzepatide 🚨 Important Update on Compounded 🚨, As of March 19th, has officially banned compounded Tirzepatide formulations. We believe this a huge disservice to patients seeking affordable 🚨 FDA Moves to Permanently

58 Consequently, GLP-1 RAs are currently evidence-based treatments for common conditions that not only differentially affect persons with SMI-SUD but also contribute to the morbidity and mortality of these conditions

Should a patient become pregnant while using the solution, discontinuation is generally recommended until pregnancy and nursing have concluded

cardiometabolic markers

Identification and localization of a stable sulfenic acid in peroxide-treated tetrachlorohydroquinone dehalogenase using electrospray mass spectrometry

Semaglutide works primarily on the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors, creating potential synergy when used together